PRCT
HealthcareProcept BioRobotics Corp
$24.80-0.38 (-1.51%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PRCT Today?
No stock-specific AI insight has been generated for PRCT yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$1.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding56.9M
PRCT News
21 articles- How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance ResetYahoo Finance·May 4, 2026
- PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS LaunchYahoo Finance·May 1, 2026
- PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & JuneYahoo Finance·Apr 30, 2026
- Procept (PRCT) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- PROCEPT BioRobotics Corporation Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...Yahoo Finance·Apr 30, 2026
- PROCEPT BioRobotics Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 29, 2026
- PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsYahoo Finance·Apr 29, 2026
- Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBenzinga·Apr 22, 2026
- PROCEPT BioRobotics (PRCT) Earnings TranscriptMotley Fool·Apr 14, 2026
- PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026Yahoo Finance·Apr 9, 2026
- Inogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?Yahoo Finance·Apr 8, 2026
- EAU Upgrade Puts Aquablation And PROCEPT BioRobotics In FocusYahoo Finance·Mar 27, 2026
- PROCEPT BioRobotics (PRCT) Strengthens Its Case with Expanding System BaseYahoo Finance·Mar 26, 2026
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare SystemsYahoo Finance·Mar 24, 2026
- EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPHYahoo Finance·Mar 23, 2026
- PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® TherapyYahoo Finance·Mar 12, 2026
- Procept BioRobotics price target lowered to $30 from $47 at TruistYahoo Finance·Mar 3, 2026
- PROCEPT BioRobotics Investor Day: 2026 growth targets, higher ASPs, and profitability roadmapMarketbeat·Mar 1, 2026
- A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 OutlookYahoo Finance·Feb 28, 2026
All 21 articles loaded
Price Data
Open$24.41
Previous Close$25.18
Day High$24.99
Day Low$23.16
52 Week High—
52 Week Low—
Fundamentals
Market Cap$1.4B
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding56.9M
About Procept BioRobotics Corp
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—